title: Alterations in the water intake caused by central inhibition of angiotensin-converting enzyme in the rat.
abstract: In the present study we investigated the effects of central (i.c.v.) and subcutaneous (s.c.) injections of a 2 micrograms dose of lisinopryl, an inhibitor of angiotensin I(ANGI)-converting enzyme (CE), on water intake. I.c.v. but not s.c. injection of lisinopryl abolished drinking in response to s.c. isoprenaline (100 micrograms/kg) and significantly reduced drinking in response to 24 h water deprivation or s.c. polyethylene glycol (30% w/v, 10 ml/kg). Lisinopryl had no effect on water intake induced by cellular dehydration (s.c. injection of hypertonic saline (2 M NaCl)). These results are consistent with the hypothesis that lisinopryl acts as a CE blocking agent in the brain. The thrist challenge induced by hypotension using isoprenaline acts primarily by generating ANGII systemically and centrally. The other thirst challenges such as cellular dehydration are independent of the ANGII in the brain. This conclusion was made possible by utilizing a new CE blocking agent at a smaller dose than normally used for other ANG I-CE inhibitors.
authors.affiliation: Department of Physiology, School of Dentistry, Paulista State University, Araraquara, SP, Brazil.
authors.forename: W A
authors.initials: WA
authors.lastname: Saad
authors.forename: L A
authors.initials: LA
authors.lastname: Camargo
authors.forename: A
authors.initials: A
authors.lastname: Renzi
authors.forename: L A
authors.initials: LA
authors.lastname: de Luca Júnior
authors.forename: J
authors.initials: J
authors.lastname: Antunes-Rodrigues
authors.forename: W A
authors.initials: WA
authors.lastname: Saad
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology*; D004327:Drinking Behavior / Q000187:drug effects*; D004656:Enalapril / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D007276:Injections, Intraventricular; D007279:Injections, Subcutaneous; D007545:Isoproterenol / Q000008:administration & dosage / Q000494:pharmacology; D017706:Lisinopril; D008297:Male; D051381:Rats; D012016:Reference Values; D012462:Saline Solution, Hypertonic; D013997:Time Factors
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D012462:Saline Solution, Hypertonic; D004656:Enalapril; D017706:Lisinopril; D007545:Isoproterenol